For instance, we found that SLC34A2 was downregulated in COAD and BLCA, while previous studies reported that this transporter was upregulated in tumor tissues of colorectal and bladder cancer patients (Ye et al., 2017; Yang Y. et al., 2022). This evidence concerns the gene SLC34A2 and neoplasm.